Play

Patients are at the center of a new app to help people improve their cardiovascular health called Corrie. Corrie was developed at Johns Hopkins by Seth Martin, a cardiologist, and colleagues to help those who’ve had a heart attack implement …

Can an app called Corrie help you improve your cardiovascular health? Elizabeth Tracey reports Read more »

Play

If you’ve had a heart attack a new app that’s been developed at Johns Hopkins could help you avoid a second one by engaging you in your own care. Seth Martin, a cardiologist at Hopkins and one developer of this …

Getting expert help in avoiding a second heart attack may be as close as your mobile phone, Elizabeth Tracey reports Read more »

Play

Deprescribing is an effort underway among primary care physicians to completely assess all medicines a person is taking, including vitamins, supplements and over the counter medicines, and reduce that number to the fewest possible while still achieving therapeutic goals. Caleb …

Check in with your doctor to see if you need deprescribing, Elizabeth Tracey reports Read more »

Play

Implantable recorders, which are placed under the skin and monitor someone’s heart for a prolonged period of time, may help identify a heart condition known as atrial fibrillation in those who’ve had a stroke, two recent studies find. Michele Johansen, …

Should you have a monitor placed under your skin to monitor your heart if you’ve had a stroke? Elizabeth Tracey reports Read more »

Play

For people who’ve had a stroke, finding out why will dictate their management going forward, with a pair of new studies showing that an implantable monitor to look for atrial fibrillation, where part of the heart doesn’t beat in synchrony, …

Finding out why a stroke took place is key to preventing a second one, Elizabeth Tracey reports Read more »

Play

Medicare is poised to spend millions of dollars on aducanumab, a just approved drug for Alzheimer’s disease the FDA’s own advisory panel recommended against approving. Caleb Alexander, a member of the panel and an internal medicine expert at Johns Hopkins, …

A confirmatory trial for a new Alzheimer’s disease drug is many years away, Elizabeth Tracey reports Read more »